Fund Holdings — Essex Woodlands Management, Inc.

Total Portfolio Value
$350.40M
Total Bought
$0
Total Sold
$0
Net Transaction
$0
Filing Period:
Securities
▲▼
SharesValue ($K)
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
BIOVENTUS(BVS)13,021,32413,021,324074,873155,60544.41%+80,732
REVANCE THERAPEUTICS INC457,085457,08501,1752,3720.68%+1,198
MEDICINOVA INC(MNOV)1,105,9411,105,94101,5932,3220.66%+730
VENUS CONCEPT, INC.1,089,1901,089,19008536650.19%-188
EYEPOINT PHARMACEUTICALS INC(EYPT)1,551,5211,551,521013,49812,3973.54%-1,102
TELA BIO, INC.(TELA)4,110,7094,110,709019,32010,4002.97%-8,920
MIMEDX GROUP, INC.(MDXG)28,195,24928,195,2490195,393166,63447.56%-28,759
Page 1 of 1
Essex Woodlands Management, Inc. — 13F Holdings — Q3 2024 | TickerTrail